Apomorphine Infusion Experiences in Parkinson's Disease

This study is focused on understanding the real-world experiences of patients in the United States using a treatment called ONAPGO, which is a continuous subcutaneous apomorphine infusion, specifically designed for individuals with Parkinson's Disease. Parkinson's Disease is a condition that affects movement and can cause tremors, stiffness, and other symptoms. The study aims to gather insights into how patients manage their symptoms using ONAPGO in everyday life. This information is crucial because it helps healthcare providers better understand the practical aspects of using this treatment and can lead to improved care strategies for those living with Parkinson's Disease. Participants in the study go through several stages, starting with an Enrollment Day when they first receive their prescription for ONAPGO. Before starting the infusion, there is a Baseline Period where patients receive in-home education from a Clinical Nurse Navigator on how to use ONAPGO properly. The study involves different phases, including starting the dose, adjusting it as needed, and maintaining the treatment. Throughout the study, participants receive regular care visits from their nurse to ensure proper management of the treatment. At the end of the study, or if they decide to stop the treatment, participants have a final visit to review their experiences. The study does not involve any interventions beyond standard care, and it focuses on observing how the treatment fits into the daily lives of those with Parkinson's Disease.